Abstract

We have developed a high yield technique for isolating ventricular myocytes from adult mouse hearts. This collagenase-trypsin procedure yields 3–6×106cells/heart. The cells are rod-shaped, roughly 20μM ×100 μM and Ca++tolerant, with viability of 65–80%. Binding studies with [125I]ICYP demonstrate the presence of β -adrenergic receptors at a density of 83 fmol/mg membrane protein. Assessment of the effects of the β1-specific antagonist CGP 20712A on [125I]ICYP binding and on isoproterenol (ISO)-sensitive adenylyl cyclase activity indicates that 67% of the receptors are β1and 33% are β2, compared to 16–20%β2in rat myocytes. Mouse myocytes respond to isoproterenol to produce cyclic AMP with an EC50≈110±20 n M. A functional Gipathway is demonstrated by inhibition of ISO-stimulated cyclic AMP accumulation by endothelin, carbachol and ATP and by sensitivity of this inhibition to pertussis toxin. As assessed by inositol phosphate production, endothelin and ATP stimulate the activity of the Gq-phospholipase C pathway, whereas carbachol, PGF2 αand α1-adrenergic receptor agonists show no significant effect. The inability of α1-adrenergic receptor agonists to induce phosphoinositide hydrolysis in mouse myocytes differs from a several fold α1-adrenergic activation that occurs in rat. Biochemical and pharmacological profiles, as well as the need for modifications in experimental design, indicate that mouse myocytes differ substantially from rat cardiac myocytes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.